Latest oppositions filed by Ucb Pharma Gmbh

This table presents recent patent oppositions filed by Ucb Pharma Gmbh against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3345607Methods Of Altering Bone Growth By Administration Of Sost Or Wise Antagonist Or AgonistOSSIFI-MAB LLCJul 26, 2023

The following table provides an overview of the latest patents of Ucb Pharma Gmbh that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3145504Jul 26, 2023Transdermal Delivery System Including An Interface Mediator1
EP2645997Aug 10, 2022Once Daily Formulation Of Lacosamide1
EP2992891Aug 5, 2020Pharmaceutical Composition Comprising Brivaracetam And Lacosamide With Synergistic Anticonvulsant Effect1
EP2515887Jun 6, 2018Polyvinylpyrrolidone For The Stabilization Of A Solid Dispersion Of The Non-Crystalline Form Of Rotigotine2
EP2037965Aug 30, 2017Pharmaceutical Composition With Synergistic Anticonvulsant Effect1
EP2922533Jun 14, 2017Multi-Day Patch For The Transdermal Administration Of Rotigotine2